If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Half Year 2023 Trading Update

18 May 2023 07:00

RNS Number : 7856Z
IDOX PLC
18 May 2023
 

18 May 2023

Idox plc

('Idox' or the 'Group' or the 'Company')

Half Year 2023 Trading Update

Good first half performance, positive momentum and continued cash generation

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial half year ended 30 April 2023 ('FY23 H1').

 

 

Group trading performance

 

We are pleased to report that the Group has delivered a good performance during the first six months of the year with year-on-year adjusted EBITDA growth of c.10%. Operating under a new tripartite divisional structure of Land, Property & Public Protection, Communities and Assets, the Group continues to make encouraging progress in its chosen markets.

 

The Group delivered a significant increase in order intake during the period of c.£52m (up 23% from FY22 H1) providing good levels of recurring revenue visibility for the remainder of FY23 and into FY24.

 

The Board expects to report a c.10% increase in adjusted EBITDA to c.£12m, in line with management expectations. Revenue was up c.8% to c.£36m, within which recurring revenue was up c.7% over the period to c.£21m.

 

The Group continued to generate strong cash flow during the period and ended the half with a net cash position of c.£1m compared to a net debt position of £6.7m as at 31 October 2022 (net debt of £3.8m as at 30 April 2022).

 

 

David Meaden, Chief Executive of Idox commented:

 

"The Group has delivered a good performance for the period in a challenging macro-economic environment.

 

We have continued to secure both new clients and new contracts with key customers, which has resulted in significantly higher order intake, providing good visibility into the future. As anticipated, the Group has delivered double digit profit growth in the period.

 

Our focus on cash generation has ensured we ended the period with net cash, compared to net debt at the year end. Combined with our available debt facilities, this enables us to continue to pursue attractive acquisition targets that we believe will generate value for all shareholders.

 

We are pleased with our progress and momentum and are on track to deliver on our plans for the remainder of 2023."

 

 

Notice of half year results

 

The Group expects to report its FY23 H1 results on Thursday 8 June 2023. Management will host a results webinar on the day. Please contact MHP to register your interest.

 

 

1 Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

2 Net cash / (debt) is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Anoop Kang, Chief Financial Officer

 

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Michael Burke

James Smith

 

MHP

+ 44 (0) 20 3128 8170

Reg Hoare 

Ollie Hoare

Matthew Taylor

idox@mhpgroup.com

 

 

About Idox plc

For more information see www.idoxgroup.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGMKVNZGFZM
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.